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Dendritic cells (DCs) flexibly adapt to different micro-
environments by using diverse migration strategies
that are ultimately dependent on the dynamics and
structural organization of the actin cytoskeleton.
Here, we have shown that DCs require the actin
capping activity of the signaling adaptor Eps8 to
polarize and to formelongatedmigratoryprotrusions.
DCs from Eps8-deficient mice are impaired in direc-
tional and chemotactic migration in 3D in vitro and
are delayed in reaching the draining lymph node
(DLN) in vivo after inflammatory challenge. Hence,
Eps8-deficient mice are unable to mount a contact
hypersensitivity response. We have also shown that
the DC migratory defect is cell autonomous and that
Eps8 is required for theproper architectural organiza-
tion of the actin meshwork and dynamics of cell
protrusions. Yet, Eps8 is not necessary for antigen
uptake, processing, and presentation. Thus, we
have identified Eps8 as a unique actin capping pro-
tein specifically required for DC migration.
INTRODUCTION
Dendritic cells (DCs) are essential for the initiation of the acquired
immune response, during which they capture and present anti-
gens, undergo maturation, and migrate from peripheral tissues
to nearby lymph nodes to activate T cells (Randolph et al.,
2008). To perform these functions, DCs flexibly adapt their adhe-
sive, actin-based structures and migratory properties. For
example, the migration of immature DCs from the bone marrow
(BM), where they are produced, to peripheral tissues is thought
to involve the formation of prototypical adhesive, actin-rich,
and highly invasive podosomes (Pierre et al., 1997; West et al.,
2004). Exposure to endogenous or exogenous ‘‘danger’’ signals
induces the differentiation of DCs into a motile state, which is
associated with loss of adhesive structures and properties,
including podosomes and integrin-based cell-matrix interac-388 Immunity 35, 388–399, September 23, 2011 ª2011 Elsevier Inc.tions (Pierre et al., 1997; West et al., 2004). These events enable
DCs to adopt a flexible nonadhesive mode of motility driven
mainly by protrusive actin flows at the cell front, while actomy-
osin contraction at the rear serves to squeeze and propel the
nucleus through gaps in the extracellular matrix (ECM) (La¨mmer-
mann et al., 2008). Within this context, regulators of actin
dynamics, including actin bundlers and capping proteins, are
expected to play a critical role by controlling the architecture
and dynamics of the actin meshwork that propels nonadhesive
DC migration.
Among these molecules, Eps8 is a unique actin binding and
signaling protein that possesses actin filament bundling and
capping activities, the coordination of which is important for
the generation of various types of protrusions in both sessile
and highly migratory cells (Hertzog et al., 2010). Eps8 is the
prototype of the Eps8L family of capping proteins, which
includes four related and functionally redundant genes in mam-
mals (Disanza et al., 2004; Offenha¨user et al., 2004). Eps8Lmole-
cules display a modular domain organization more typically
found in signaling adaptors and scaffolds (Offenha¨user et al.,
2004; Tocchetti et al., 2003). Accordingly, Eps8 participates in
the formation of distinct macromolecular complexes that either
transduce signals from Ras to Rac leading to actin remodeling
or regulate endocytosis of receptor tyrosine kinases (Lanzetti
et al., 2000; Scita et al., 1999). The isolated C-terminal domain
(aa 648–821) caps barbed ends in the nanomolar range, but it
is inhibited in the context of the full-length protein (Croce et al.,
2004; Disanza et al., 2004). Unlike other cappers, full-length
Eps8 has also been shown to organize actin filaments into
higher-order structures, and this crosslinking activity is en-
hanced by interaction with insulin receptor tyrosine kinase
substrate p53 (IRSp53) (Abbott et al., 1999; Disanza et al.,
2006; Funato et al., 2004; Oda et al., 1999). The molecular basis
of the capping and bundling activities of Eps8 have recently been
unveiled; Eps8 can wrap around filaments, contacting the
barbed end actin unit through an amphipathic helix that is essen-
tial for blocking the addition of further monomers, while extend-
ing itsC-terminal globular core along the filament side in a config-
uration that allows Eps8 to crosslink filaments (Hertzog et al.,
2010). Single-point mutagenesis has allowed the dissection of
these distinct Eps8 activities both in vitro and in vivo, providing
clues as to their functional relevance in cell migration and
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DC Migration Requires the Actin Capper Eps8morphogenesis of actin structures, such asmicrovilli and stereo-
cilia (Croce et al., 2004; Hertzog et al., 2010; Manor et al., 2011;
Tocchetti et al., 2010).
On the basis of these considerations, we hypothesized that
Eps8 may be critical in DC migration. Here, we show that Eps8
is expressed in DCs. Using an Eps8-deficient mouse model
and in vitro assays of DC migration, we have demonstrated
that Eps8 is essential for DC trafficking in vivo and DC migration
in 2D and 3D in vitro. Eps8 mediates these processes by pro-
moting, through its capping activity, the formation of a dense
actin meshwork, which is, in turn, essential for sustaining persis-
tent and extended cell protrusions. Thus, Eps8 is a critical
capping protein for DC migration.
RESULTS
Eps8 Is Required for DC Elongated Cell Shape In Vitro
and Migration to Lymph Nodes In Vivo
In mammals, Eps8 is a member of an Eps8L protein family that
includes three additional highly conserved, functionally redun-
dant gene products (Offenha¨user et al., 2004; Tocchetti et al.,
2003). We, therefore, first examined the expression pattern of
Eps8L mRNAs in bone marrow-derived DCs (BMDCs) of wild-
type (WT) or Eps8-deficient mice. We detected significant
amounts only of Eps8 mRNA, but not Eps8L1, Eps8L2 or
Eps8L3 mRNAs in WT BMDCs (Figure S1A available online).
Furthermore, genetic removal of Eps8 was not accompanied
by a compensatory elevation of the mRNA of the other family
members. Notably, Eps8 expression in spleen-derived DCs
was far superior than that in other innate and adaptive immune
cells, such as macrophages, neutrophils, and T and B cells (Fig-
ure S1B). Thus, Eps8 might play a unique nonredundant function
in actin-based processes in BMDCs. Consistent with this latter
notion, Eps8 colocalized with filamentous actin both in immature
and lipopolysaccharide (LPS)-matured DCs. Eps8 was promi-
nently localized to podosomes in immature BMDCs, whereas it
was enriched at lamellipodia leading edgeofmigratory andpolar-
ized mature BMDC (Figures S1C and S1D). Genetic removal of
Eps8 did not affect the formation or the number of podosomes,
or their ability to adhere or degrade the extracellular matrix
(ECM) (data not shown), but altered the shape of both immature
and LPS-stimulated BMDCs (Figures S1C and S1D). Eps8/
BMDCswere significantly rounder thanWT cells, whereas podo-
somes, which are frequently polarized in WT immature BMDC,
were distributed uniformly in Eps8/ BMDCs (Figure S1D).
Eps8 expression was not regulated during DC maturation by
LPS (Figure S2). Consistently, Eps8 was dispensable for DC
maturation as witnessed by a similar expression pattern of
various cell surface activation markers and cytokines (Figures
S2A and S2C), that are upregulated during DC maturation.
Thus, Eps8 is the main Eps8L family member expressed in
BMDCs and represents an abundant actin regulatory protein
that is dispensable for the adhesive and degradative properties
of BMDCs, but essential for the acquisition of a polarized and
elongated cell shape. These data support the notion that Eps8
might be critical for DC migration.
To test this possibility, we analyzed DC migration in response
to epicutaneous challenge with a skin irritant that promotes their
migration to draining lymph nodes (DLNs) (Akiba et al., 2002).ImThis process is crucial to mount skin immunity (Itano et al.,
2003; Sullivan et al., 1986). We, therefore, tested the importance
of Eps8 in this very first migratory phase by combining the
administration of fluorescein iso-thiocyanate (FITC), which fluo-
rescently labels skin-resident DCs, with the irritant (dibutyl
phthalate), which induces DC maturation and mobilization from
peripheral, cutaneous tissues to DLNs.We painted the abdomen
of WT and Eps8/mice with FITC and dibutyl phthalate and as-
sessed migration of FITC-positive DCs by flow cytometry (Dear-
man et al., 1996). The number of dermal DCs (CD24-CD207 and
CD24CD207+) and Langerhans cells (LC; CD24+CD207+)
migrating to the DLNs was substantially reduced in Eps8/ as
compared toWTmice (Figures 1A and 1B). Notably and as previ-
ously reported (Kissenpfennig et al., 2005), the more numerous
and faster population of DCs arriving at the DLNs are dermal
DCs in both mouse backgrounds. However, in Eps8/ mice
dermal DCs were less impaired than LC in their migration as their
percentage (relative to migrated FITC+ major histocompatibility
complex class II [MHCII]+ cells) was increased at all time points
(Figure 1C), even though their absolute numbers remained lower
than in WT mice (Figure 1D, upper panel). Prompted by this
result, we also determined the frequency of various DC subtypes
under steady state conditions in the skin DLNs as well as in the
skin of WT and Eps8/ mice. DLNs from Eps8/ mice dis-
played a reduced number of all analyzed DC subtypes with
respect to WT DLN (Figures S3A–S3C). Conversely, the distribu-
tion and number of LCs and dermal DCs determined by immuno-
fluorescence analysis of epidermal sheets and dermal explants,
respectively, of WT and Eps8/ mice was nearly identical
(Figures S3D and S3E). Collectively, these results indicate that
Eps8, which is expressed to various extents in virtually all DC
subtypes (Figure S3F), is required for optimal accumulation
into DLNs of activated DCs that migrate from the periphery
through interstitial tissues, but is not required for the seeding
of DC progenitors in the skin.
Delayed-Type Hypersensitivity Is Impaired in Eps8–/–
Mice Because of DC Migration Deficiency
Because interstitial migration of peripheral DCs is also essential
for the priming of CD8+ T cells in cutaneous DLNs and mounting
of an immunological response (Akiba et al., 2002), we next ad-
dressed whether Eps8 is also required for skin immunity by per-
forming a contact hypersensitivity (CHS) assay. WT and Eps8/
mice were sensitized by topical application of oxazolone (OXA)
as a hapten (Wang et al., 1997b), and, after 5 days, further chal-
lenged by application of the hapten onto the right ear. WT mice
responded with a voluminous swelling of the right ear, whereas
the left ear treated with vehicle alone remained normal. In
contrast, swelling of the right ears of Eps8/mice was reduced
and OXA-treated ears were nearly indistinguishable from
vehicle-treated ears or ears prior to OXA application (Figure 2A).
Histological analysis further confirmed that the swelling of WT,
but not of Eps8/ mice ears was accompanied by a massive
cellular infiltration and edema (Figure 2B).
To assess whether the defect in DC migration observed in
Eps8/ mice was cell autonomous or due to lack of Eps8
expression in other tissue compartments, we performed two
sets of experiments. In the first set, we tested the delayed-type
hypersensitivity (DTH) response after injection of ovalbuminmunity 35, 388–399, September 23, 2011 ª2011 Elsevier Inc. 389
Figure 1. Skin Irritant-Induced DC Migra-
tion to Cutaneous DLNs Is Impaired in
Eps8 Null Mice
(A) The percentage of FITC+ MHCII+ skin cells
migrating to inguinal DLNs of WT (Eps8+/+) or
Eps8/ (Eps8/) mice painted on the abdomen
with 0.5% FITC in 1:1 acetone:dibutylphtalate
mixture was assessed by flow cytometry. Num-
bers in the gate are the percentage of FITC+
MHCII+ positive cells (6 mice/group, two inde-
pendent experiments).
(B) The absolute numbers of FITC+MHCII+CD11c+
cells migrating to the DLNs at different time points
in WT (Eps8+/+) and Eps8-deficient (Eps8/)
animals. Data represent the mean ± SD (6 mice/
group, out of two independent experiments).
(C)FITC+MHCII+CD11c+cellswereanalyzed for the
expression of CD24 and CD207. Numbers in the
quadrants show the percentage of positive cells.
(D) The absolute numbers of FITC+ dermal DCs
(CD24 CD207), langerin dermal DCs (CD24
CD207+) and Langerhans cells (CD24+ CD207+)
migrating to the DLNs at different time points inWT
(Eps8+/+) and Eps8-deficient (Eps8/) animals.
Data represent themean ± SD (n = 6mice/group of
two independent experiments); *p < 0.05; **p <
0.01; ***p < 0.001.
Immunity
DC Migration Requires the Actin Capper Eps8(OVA)-loaded Eps8/ DCs into WT mice and vice versa (WT
DCs injected into Eps8/ mice). The adoptive transfer of WT
DCs into Eps8/ mice restored the DTH response, which,
however, remained significantly impaired in WT mice injected
with OVA-pulsed Eps8/ DCs (Figure 2C). Next, we compared
the migratory properties of WT and Eps8/ BMDCs injected
subcutaneously in WT mice. LPS-matured BMDCs were labeled
with two distinct fluorescent dyes and simultaneously injected
into the footpad of C57BL/6mice. Their migration to the popliteal
DLN was monitored 1 day after transfer. We found a robust and
highly significant decrease in the migration of Eps8-deficient
BMDCs to the DLN compared with WT BMDCs (Figure 3A).
Similar to WT DCs, the few Eps8/ DCs that reached the DLN
localized to the T cell area and were not retained anywhere
else in the LN (Figure 3A). These data reinforce the notion that
cell-autonomous, migratory defects of DCs, and not Eps8
deficiency in other immune or nonimmune cells, are primarily
responsible for the lack of CHS and DTH responses.
Impaired Migration of Eps8–/– BMDCs Results
in Defective T Cell Priming In Vivo
Next, we determined whether genetic removal of Eps8, in addi-
tion to preventing migration of antigen-loaded BMDCs to the
DLN, also affected the subsequent activation of T cells. We390 Immunity 35, 388–399, September 23, 2011 ª2011 Elsevier Inc.adoptively transferred carboxyfluores-
cein diacetate succinimidyl ester
(CFSE)-labeled CD4+ naive OT-II Ly 5.2
T cells, derived from transgenic mice ex-
pressing a T cell receptor (TCR) that
specifically recognizes an OVA peptide
(OVA323-337) in association with MHC
class II molecules (Barnden et al., 1998),
to C57BL/6 Ly 5.1 mice. After 1 day,
mice were injected into the footpad with matured WT or Eps8/
BMDCs and loaded in vitro with OVA; we evaluated T cell prolif-
eration by monitoring CSFE dilution of CD4+ Ly 5.2 T cells iso-
lated from popliteal DLNs. The total number and the proliferation
of Ly 5.2 CD4+ T cells were significantly lower after immunization
with OVA-loaded Eps8/ BMDCs with respect to OVA-loaded
WT BMDCs (Figure 3B). This was not due to defects in antigen
uptake or processing by Eps8/ BMDCs (Figures S4A and
S4B). Moreover, it could not be accounted for by defects in the
ability of OVA-loaded Eps8/ and WT BMDCs to induce
antigen-specific T cell proliferation and polarization (secretion
of interleukin-2 [IL-2] and interferon-g [IFN-g]) in vitro (Figures
S4C and S4D). This latter notion was reinforced and validated
by two additional approaches. First, we monitored T cell activa-
tion and polarization by WT and Eps8/ DCs in round- or flat-
bottom wells. In round-bottom wells, contacts between cells
are forced by the geometry of the well. Conversely in flat wells,
the motility and membrane protrusions activity of DCs is critical
to enable their contact and priming of T cells (Benvenuti et al.,
2004; Pulecio et al., 2008). Eps8/ DCs promoted T cell prolif-
eration and activation similarly to WT DCs in round, but not in
flat-bottom wells (Figure S5A). Under optimal conditions, T cell
polarization induced by either WT or Eps8/ DCs was also
indistinguishable as attested by a similar pattern of released
Figure 2. Impaired CHS Response to Oxazolone in
the Absence of Eps8
(A) Eps8 deficiency significantly impairs ear swelling upon
OXA sensitization. WT (Eps8+/+) and Eps8/ (Eps8/)
mice sensitized with OXA on day 0, were challenged after
5 days on the right ear with OXA. Ear thickness was
measured from 24 hr to 96 hr after challenge. Data
represent the mean swelling values of 5 mice/group of
three independent experiments. **p < 0.01; *p < 0.05.
(B) Cellular infiltrate and edema are reduced in Eps8-
deficient mice 48 hr after OXA challenge. Histological
analysis of the CHS response: WT (Eps8+/+, left panels)
and Eps8-deficient (Eps8/, right panels) mice ears,
unchallenged (top) or 48 hr after OXA challenge (bottom).
The scale bar represents 200 mm.
(C) WT (Eps8+/+, black circle) and Eps8-deficient mice
(Eps8/, open circle) immunized with WT or Eps8-defi-
cient OVA-loaded BMDCs cells were challenged with OVA
in the right footpad and vehicle in the left footpad. Data
represent the mean swelling values of 5 mice/group of two
independent experiments. **p < 0.01; *p < 0.05.
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DC Migration Requires the Actin Capper Eps8cytokines (Figure S5B). Second, we tested the priming of adop-
tively transferred, transgenic CFSE-labeled CD4+ naive OT-II Ly
5.2 T cells by a large amount of OVA-loaded Eps8/ BMDCs in-
jected into the footpad of C57BL/6 Ly 5.1 mice. Under these
conditions, larger number of Eps8/ BMDCs reached the DLNImmunity 35, 388–3(Figure S5C) and induced T cell proliferation to
similar extent as OVA-loaded WT BMDCs
(Figure S5C).
Thus, Eps8 deficiency does not directly affect
DC antigen processing or presentation; rather,
it results in a cell-autonomous defect in cell
trafficking, which impairs DC migration and ulti-
mately causes defective T cell priming.
Eps8 Removal Impairs Chemotactic
BMDCs Motility in 2D and 3D In Vitro
To investigate the cellular and molecular mech-
anisms underlying Eps8 effects on DC migra-
tion, we performed a battery of in vitro migratory
assays. We initially tested the chemotactic
migratory ability of mature WT and Eps8/
BMDCs in Transwell assays. LPS-stimulated
Eps8/ BMDCs were significantly impaired in
CCL19-chemotactic migration both under
conditions in which no ECM was added to the
Transwell (Figure S6A) or when a Matrigel inva-
sion chamber were used (Figure S6B), mim-
icking 2D and 3D cell motility, respectively. In
the latter case, both the total number of cells
crossing the invasion chamber and the number
of CSFE-stained Eps8/ BMDCs visualized in
the process of invading a section of the Matrigel
plug were significantly reduced compared with
WT BMDCs (Figure S6B). The apparent migra-
tory defect ofEps8/BMDCsmay reflect either
a lack of response to chemotactic signals or an
intrinsic defective ability of these cells to sustain
directional motility, possibly as a consequenceof defects of the actin cytoskeletal network supporting cell
locomotion. The latter possibility was supported by the observa-
tions that Eps8 null BMDCs were also impaired in Transwell
migration under conditions where no chemokine was added to
the bottom chamber (data not shown).99, September 23, 2011 ª2011 Elsevier Inc. 391
Figure 3. Impaired Trafficking and Antigen
Presentation in DLNs of Subcutaneously In-
jected Eps8-Deficient DCs
(A) Eps8-deficient DCs fail to migrate to DLNs.
LPS-treated WT (Eps8+/+) or Eps8/ (Eps8/)
BMDCs were stained with either eFluor670 or
CFSE, respectively. An equal number (1.5 3 105)
of WT and Eps8/ labeled BMDCs were injected
in the footpad. The number of migrated BMDCs to
the popliteal DLN was assessed by flow cytometry
after 24 hr. The top-left panel is a representative
dot plot of three independent experiments. The
percentage of eFluor670- or CFSE-positive DLN
cells is shown. The top-right panel shows a
confocal section of a popliteal DLN after migration
of eFluor670-labeled WT (Eps8+/+), CFSE-labeled
Eps8/ (Eps8/) BMDCs, and anti-CD3 staining
for visualization of the T cell area. The scale bar
represents 250 mm. Data represent mean ± SD
(n = 5 mice). **p < 0.01; *p < 0.05.
(B) Eps8/ DCs fail to migrate to DLNs and to
prime naive T cells. C57BL/6 Ly 5.1 mice were
adoptively transferred with 2 3 106 CFSE-labeled
CD4 naive OT-II Ly 5.2 T cells. After 24 hr, mice
were injected in the right or in the left footpad with
1.5 3 105 WT (Eps8+/+) or Eps8/ (Eps8 /)
mature Ova-loaded BMDCs, respectively. The
popliteal DLNs were analyzed for assessing the
percentage of CD4 Ly 5.2 T cells and the prolif-
eration via CFSE dilution after 3 d. Left panels
show the percentage of CD4+ and CD45.2+ posi-
tive cells in the DLN is shown. The middle panel
shows the percentage of proliferated CD4+ and
CD45.2+ T cells. Right panels show histograms of
CFSE dilution in CD4+CD45.2+ T cells. Numbers
above lines is the percentages of proliferating
cells. Data represent the mean ± SD (n = 5 mice/
group) of three independent experiments; **p <
0.01, *p < 0.05.
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DC Migration Requires the Actin Capper Eps8To gain further clues in this direction, we monitored BMDC
motility in under-agarose assays where cells are squeezed
between a layer of agarose and a coverslip. This constrained
environment mimics the motility in 3D while affording real-time
analysis of individual cell locomotion as well as quantitative
measurements of various parameters of cell motility and cell
protrusions dynamics (Heit and Kubes, 2003). Mature WT and
Eps8/ BMDCs were either exposed to a diffusion gradient of
CCL19 or uniformly stimulated with the inclusion of CCL19 in
the agarose layer. Tracking of individual cell motility revealed
that Eps8 null cells had a significant reduced CCL19 forward
migration index, a measure of persistent motility toward
a chemotactic stimuli, accompanied by a slight, albeit not signif-392 Immunity 35, 388–399, September 23, 2011 ª2011 Elsevier Inc.icant, reduction of cell speed (Figure 4A
and Movie S1). Remarkably, this defect
was not limited to cells moving along
a diffusive gradient, given that directional
persistence (and speed of Eps8/
BMDCs) was significantly reduced also
when random cell motility was analyzed
(Figure 4B and Movie S2). Thus, Eps8
removal does not strictly impair CCL19sensing or chemotactic signaling pathways but is more generally
required for persistent directional motility of DCs. The finding
that CCL19-stimulated and unstimulated, mature WT and
Eps8-deficient BMDCs display similar amounts of GTP-bound,
activated Rac as well as of a number of signaling kinases (AKT,
Erk1, Erk2, and JNK) (Figures S7C and S7D) is consistent with
the former notion.
Next, we analyzed WT and Eps8/ BMDC motility in a 3D
collagen type I gel because 3D migration substrate that more
closely resembles the complex fibrillar environment of dermal
interstitial tissues. Collagen type I gels containing CCL19 were
polymerized into a homemade chamber on a glass coverslip
(Friedl and Bro¨cker, 2004). On one side of the chamber, WT or
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Figure 4. Genetic Removal of Eps8 Impairs
Directional Motility of BMDCs in Under-
Agarose Assays
(A) An equal number of LPS-activated WT
(Eps8+/+) and Eps8/ (Eps8/) BMDCs were in-
jected between a glass coverslip and an agarose
layer. Cells were induced tomigrate toward a 2mm
afar attractor hole containing CCL19. Migration
tracks of randomly picked cells are shown on the
left (see also Movie S1). The forward migration
index and mean velocity (right graphs) ± SD are
shown. At least 30 single cells /experiment/geno-
type were tracked. n.s. not significant; **p < 0.01.
(B) Random BMDC migration in a planar under-
agarose assay. BMDCs were treated as in (A) and
injected between a glass coverslip and a layer of
agarose. Data are presented as in (A) except that
the directionality index is reported instead of
forward migration index (right graphs). (see also
Movie S2). At least 30 single cells/experiment/
genotype (three independent BMDC preparations)
were tracked. Data are the mean ± SD. n.s. not
significant; *p < 0.05.
Immunity
DC Migration Requires the Actin Capper Eps8Eps8/ BMDCs were added before sealing the chambers for
video microscopy analysis. WT BMDCs entered efficiently into
the gel moving directionally (directionality index, 0.53) at
2 mm/min average velocity. In contrast, Eps8/ BMDCs
were significantly slower (average velocity,1 mm/min), and dis-
played a significantly reduced persistent motility (directionality
index, 0.2) (Figure 5 and Movie S3). Thus, removal of Eps8Immunity 35, 388–399, Seseverely impairs the ability of BMDCs to
move in a geometrically defined 3D envi-
ronment fully recapitulating the severe
migration defect observed in vivo.
A corollary prediction of this latter
hypothesis is that Eps8/ BMDCs
moving in a confined 3D environment
may be specifically defective in either the
formation or maintenance of cell protru-
sions, the first step of cell locomotion. To
verify this prediction, we embedded
BMDCs in collagen scaffolds before expo-
sure to CCL19 and visualized migrating
cells at high magnification and resolution
to monitor cell protrusion dynamics.
Although WT BMDCs extended long pro-
trusions that led the way to cell transloca-
tion toward CCL19, more than 80% of
Eps8/BMDCs displayed a round, unpo-
larized morphology, tumbled around, and
failed to effectively translocate their center
of mass (Figure 6A, Movie S4). To exem-
plify and simplify the analysis of the
morphological changes and protrusion
extension during 3D migration, we traced
the cell contour of maximal 3D projection
over 5 min of cell translocation (Figure 6B,
Movie S4). WT cells frequently extended
a persistent protrusion that imposed a
polarizedmorphologywith clearly discern-ible advancing and trailing edges. Conversely, Eps8/ BMDCs
formed short-lived protrusions and did not adopt a polarized
morphology (Figure 6B). Importantly, Eps8/ BMDCs altered
morphological changes and protrusion dynamics could be fully
restored by re-expression a wild-type, full-length, GFP-tagged
Eps8, formally demonstrating the requirement of Eps8 for BMDC
migration morphology (Figure 6C, upper panels, and Movie S5).ptember 23, 2011 ª2011 Elsevier Inc. 393
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Figure 5. Genetic Removal of Eps8 Impairs
ChemotacticMotility of BMDC in 3DCollage
Matrix Chamber Slides
(A) An equal number of LPS-activated WT
(Eps8+/+) and Eps8/ (Eps8/) BMDCs were
placed on one side of a chamber slide in which
1.6 mg/ml polymerized collagen type I gel con-
taining 1.2 mg/ml CCL19 was added (Friedl and
Bro¨cker, 2000). A time sequence of migratory WT
and Eps8/BMDCs is shown (see alsoMovie S3).
The scale bar represents 150 mm.
(B and C) Migration tracks of randomly picked
individual cells (B). Cell directionality (C, left graph)
and mean velocity (C, right graph) were measured.
The analysis was conducted on 35 single cells/
experiment/genotype of three independent BMDC
preparations; data are the mean ± SD. **p < 0.01.
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for Chemotactic BMDC Motility in 3D
We next addressed which of the actin regulatory activities
of Eps8 were necessary to restore BMDCs motility. Eps8
possesses both actin capping and bundling activities (Disanza
et al., 2004;Disanza et al., 2006). We recently characterized the
structural domains responsible for these Eps8 activities: an
amphipathic helix (H1), which blocks the barbed end of the fila-
ment is responsible for the capping activity, while a compact,
globular domain (H2-H5) binds, instead, to the side of filaments
and promotes bundling (Hertzog et al., 2010). Eps8 mutants
devoid of either capping (Eps8DCapping) or bundling (Ep-
s8DBundling) activities or both activities (Eps8DCapDBund)
could be generated by single-point mutagenesis, thus allowing
dissection of their functional roles (Hertzog et al., 2010). We re-
introduced these mutants into Eps8/ BMDCs and analyzed
their mode of motility in a 3D collagen gel. Although a
bundling-deficient mutant was fully capable of restoring cell
polarity and protrusion extension to such an extent that cells
became undistinguishable from WT BMDCs, the capping and
double deficient mutants failed to do so (Figure 6C and Movie394 Immunity 35, 388–399, September 23, 2011 ª2011 Elsevier Inc.S5). We conclude that Eps8 capping
activity is essential for BMDCs polarized
cell shape and protrusion extension in
3D microenvironment.
Proper Structural Organization and
Dynamics of the Lamellipodial Actin
Meshwork Requires Eps8
The essential requirement of capping
proteins for actin-based motility has
been well established through the use of
in vitro biomimetic motility assays (Bern-
heim-Groswasser et al., 2002; Loisel
et al., 1999). These results have also
been corroborated by in vivo experiments
that support a role of cappers in partici-
pating in the construction of lamellipodia
actin networks in various organisms and
model systems (Eddy et al., 1997; Iwasa
and Mullins, 2007; Mejillano et al., 2004).Indeed, genetic or functional interference with the activity of
the capping protein (CP), the most widely expressed capper,
causes loss of the lamellipodia actin meshwork and altered cell
protrusion dynamics (Iwasa and Mullins, 2007; Mejillano et al.,
2004). At the molecular level, capping proteins have been
proposed to work in concert with the Arp2/3 and actin nucleation
promoting complexes by blocking barbed ends that are densely
packed along leading edges, and thus locally enhancing the
availability of monomeric actin that become incorporated into
Arp2/3 nuclei (Akin and Mullins, 2008). This may result in
increased nucleation events and changes in the architecture of
actin networks. To address whether removal of Eps8 leads to
similar dynamic and structural alterations in BMDC protrusions
and the actin meshwork, we analyzed actin density in BMDC la-
mellipodia by platinum replica electron microscopy (EM) and
measured protrusion rates and dynamics of WT and Eps8/
BMDCs. The lamellipodia actin meshwork of BMDC displays
architecture not dissimilar from other cell types, with an array
of actin filaments variably oriented with respect to the leading
cellular edges. Notably, however, actin filaments tangentially
oriented relative to the leading edge frequently dominated over
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Figure 6. Eps8 Capping Activity Is Required for the Extension of Elongated and Persistent Cell Protrusions of BMDCs in 3D
(A and B) Eps8/ BMDCs fail to extend elongated cell protrusions and to migrate in 3D upon CCL19 stimulation.
(A) LPS-treated WT (Eps8+/+) and Eps8/ (Eps8/) BMDCs were embedded in 1.6 mg/ml collagen type I chamber slides. CCL19 (1.2 mg/ml) was added to the
top of the polymerized matrix before sealing the chamber. BMDC motility was recorded by spinning disk confocal microscopy. Still images from Movie S4 are
shown. Scale bars represent 15 mm or 10 mm.
(B) Morphology outlines of WT (Eps8+/+) and Eps8/ (Eps8/) BMDCs were obtained by morphometric analysis of 3D maximal projections. A time sequence of
representative migratory WT (Eps8+/+) and Eps8/ (Eps8/) BMDCs is shown.
(C) Eps8 capping, but not bundling activity, is required to restore Eps8/ BMDC protrusions in 3D. Eps8/ (Eps8/) BMDCs were transfected with either full-
length (FL) GFP-Eps8 or the indicatedmutants and treatedwith LPS and embedded in 1.6mg/ml collagen type Imatrix. CCL19 (1.2 mg/ml) was added in the upper
part of the polymerized gel. BMDC protrusive activity was recorded as described above (see also Movie S5). Still images from representative movies are shown.
At least 30 cells/experiment/condition of three independent BMDC preparations were analyzed by time lapse. The scale bar represents 10 mm.
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Figure 7. Eps8-Deficient BMDCs Display
Reduced Density of the Lamellipodial Actin
Meshwork and Reduced Protrusion Persis-
tence
(A) Eps8 deficiency causes a reduction in the actin
filament meshwork density of BMDC protrusions.
Platinum replica EM of lamellipodia of WT
(Eps8+/+) and Eps8/ (Eps8/) BMDCs plated as
in Figure 6 was carried out as described in Svitkina
and Borisy (1998). Low- (upper images) and
high-magnification (lower images) representative
images are shown. The scale bar of the lower
images represents 200 nm. Actin filament density
was determined as described in the Experimental
Procedures. Data are expressed as mean ± SD
(N = 75 areas from at least 15 cells/genotype);
**p < 0.01.
(B and C) GFP-actin-infected, LPS-stimulated WT
(Eps8+/+) and Eps8/ (Eps8/) BMDCs were in-
jected between a fetal bovine serum-coated, glass
coverslip and a layer of agarose as described in
Figure 6. Cells were induced to migrate toward
a 2 mm afar attractor hole containing 1.2 mg/ml
CCL19. BMDC migration was recorded by time-
lapse microscopy. Still images from representa-
tive movies (Movie S6) of WT (Eps8+/+) and
Eps8/ (Eps8/) BMDCs are shown (B, top).
Examples of kymographs performed on the indi-
cated dotted lines (four to five different areas per
cells of 10 different cells/genotype) are shown (B,
bottom).
(C) Quantification of protrusion dynamics was
carried out using kymograph image analysis soft-
ware to determine protrusion persistence (Dx),
distance (Dy), and velocity (Dy/Dx) as shown in the
upper image (C). The distribution around the mean
values of protrusion parameters of each of the ten
cells/genotype is shown (C, lower panels); **p <
0.01., n.s., not significant.
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DC Migration Requires the Actin Capper Eps8the orthogonally and diagonally oriented filaments typical for
other cells (Koestler et al., 2008; Maly and Borisy, 2001; Svitkina
and Borisy, 1999). Remarkably, the actin network of Eps8/
BMDCs’ lamellipodia appeared obviously sparser when
compared to that of WT lamellipodia (Figure 7A). Quantification
of filament density revealed that the actin network in Eps8/
BMDCs was significantly less dense than in WT BMDCs (Fig-
ure 7A), whereas no major difference in filament orientation
was observed between WT and Eps8/ cells (data not shown).
Because the geometry and stiffness of the actin meshwork have
been shown to control protrusion persistence and dynamics
(Bear et al., 2002; Mogilner and Oster, 2003), we directly396 Immunity 35, 388–399, September 23, 2011 ª2011 Elsevier Inc.measured these parameters by kymo-
graph analysis of BMDCs moving toward
CCL19. Although the rate of protrusion
extension was nearly identical between
WT and Eps8/ BMDCs, removal of
Eps8 caused a significant reduction in
protrusion persistence and length, result-
ing in the formation of much shorter and
shorter-lived lamellipodia (Figures 7B
and 7C and Movie S6). Similar resultswere obtained by monitoring with a phase contrast microscope
protrusion dynamics of untransfected BMDCs (Figures S7A and
S7B). The observation that retrograde actin flow is virtually
absent under conditions where integrin-mediated attachment
is functional, such as the one we used (La¨mmermann et al.,
2008; Renkawitz et al., 2009), further suggests that removal of
Eps8 does not affect actin polymerization (the sum of protrusion
rate and retrograde actin flow). Instead, Eps8 removal appears to
impinge mainly on the architectural organization of the mesh-
work, which is sparser, and presumably less stiff, and as such
is unable to support counter forces that oppose the elongation
by polymerization of the actin network.
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ThemolecularmechanismsenablingDCs toadapt their actinpoly-
merization rates as well as the architectural organization and
rigidity of the actin meshwork that are needed to support cellular
deformation-driven locomotion have remained largely elusive.
Here, we have shown that Eps8, through its capping activity, is a
critical, cell-intrinsic, actin regulatory factor fundamental for DC
migration within interstitial tissues in vivo and in vitro. Genetic
removal of Eps8 specifically impairs cell locomotory activity of
DC while leaving unaltered a number of other actin-dependent
properties of these cells, including integrin-mediated adhesion,
matrix degradation, andpodosome formation, aswell as immuno-
logical functions, such as cytokine secretion, antigen presenta-
tion, activation and priming of T cells, and cell survival (data not
shown). These latter results are relevant because they argue that
the function of Eps8 in DCs is to directly control the dynamics
and architectural organization of the actin meshwork, rather
than to participate in the transduction of signals leading to Rac-
dependent actin remodeling as in fibroblasts (Scita et al., 1999).
The most striking cellular defects of Eps8 null BMDCs is their
inability to extend persistent and elongated protrusions in a 3D
matrix, under conditions in which the rate of extension of indi-
vidual cell protrusion is similar to that of WT DC. This altered
protrusion dynamics prevents Eps8 null BMDCs from adopting
a defined front-to-back polarity and from extending pseudo-
podia into fluid-filled gaps of fibrillar collagen, thus driving
forward movement. The net results is that Eps8/ DCs, instead
of moving directionally, tumble around emitting short-lived,
nondirectional cell protrusions that fail to drive effective cell loco-
motion. This in vitro finding is likely to explain the impaired DC
migration observed in murine interstitial tissues. Notably, in 2D
or in under-agarose migratory setting, removal of Eps8 has
more limited effects on BMDC velocity, although it significantly
impaired directional migration and chemotactic movement. A
similar specific defective migration in 3D, but not in 2D, of DCs
has also recently been reported after the removal of Cdc42, a
small RhoGTPase critically controlling polarized migration (La¨m-
mermann et al., 2009). As with Eps8 deficient BMDCs,Cdc42/
cells are unable to migrate both in mice and in in vitro 3D motility
systems, whereas they display limited defects in a 2D setting
(La¨mmermann et al., 2009). However, there are obvious differ-
ences with respect to the phenotype of Eps8/ cells. Cdc42
null BMDC extend multiple protrusions, but that are spatially
and temporally deregulated, leading to impaired coordination
between actin flow and the leading edge. This enables cells to
move in 2D or under agarose in response to chemotactic signals
at almost the same speed asWT cells andwith limited directional
defects, but causes arrest of migration in 3D. In collagen type I
gels, Cdc42/ DCs form multiple competing protrusions that
cause instantaneous entanglement of the cells within 3D ECM
fibers (La¨mmermann et al., 2009). Conversely, Eps8 null BMDCs
are not stuck by entanglement but affected in their ability to
extend persistent protrusions particularly in a 3D microenviron-
ment. The presumably less rigid actin meshwork of Eps8/
BMDCs is unable to support the increased resistance generated
by the geometrically constrained 3D fibrillar matrix, resulting in
cells that fail to polarize along the direction determined by long-
lived pseudopodia. EM analysis of the actin meshwork, whichImis significantly less dense in Eps8/ BMDCs, supports this
contention. The extension and dynamics of pseudopodia can
be restored by re-expression of a WT Eps8 or a bundling-defi-
cient mutant, but not by a capping-deficient mutant, pointing to
a critical requirement of this activity for directional motility and
3D BMDC migration. Similar alterations in protrusion dynamics
have been reported in mesenchymal cells in which capping
activity is suppressed by RNAi against CP or by forced expres-
sion of VASP, a multifunctional actin regulator that can also exert
anticapping function (Bear et al., 2002; Mejillano et al., 2004).
Thus, one major impact of altering capping activity may be to
change the architecture and movement of the actin network
underlying cell protrusions. It is noteworthy that similar conclu-
sions as to the role of capping in actin motility have also been
reached recently with in vitro-reconstituted, biomimetic motility
systems (Akin and Mullins, 2008). According to this study,
capping proteins appear to work in concert with the Arp2/3
complex to control the rate of nucleation (Akin and Mullins,
2008). This impacts on the architectural organization of the actin
meshwork, whose stiffness and rigidity may, in turn, influence
protrusion dynamics and cell motility, particularly in microenvi-
ronments characterized by an increased resistance-load against
advancing leading edges, such as in 3D intestinal tissues.
Why Eps8 removal leads to such dramatic alterations in cells
that express also other capping proteins, including CP (data
not shown), is not entirely clear. The unique properties of Eps8
among cappers may account for this: Eps8 regulation is deter-
mined by protein:protein interactions (Disanza et al., 2004) as
well as mitogen-activated protein kinase (MAPK)-dependent
posttranslational phosphorylation (Menna et al., 2009). Within
this context, it is noteworthy that the chemokine CCL19 binding
to its receptor (CCR7) has been shown to activate two signaling
axes relevant for migration: a Rho-Pyk-cofilin axis that regulates
the velocity of DC locomotion and MAPK and Jun-N-terminal
kinase (JNK) cascades that impact on chemotaxis (Riol-Blanco
et al., 2005). Whether Eps8 is the final actin regulatory target of
the latter pathway has not been tested, but represents an inter-
esting possibility for future investigation.
What is the immunological outcome of Eps8 deficiency? Eps8
null mice do not mount a CHS response. This is paralleled by the
inability of Eps8-deficient DCs to migrate to DLNs in response to
a skin irritant, or to initiate antigen-specific T cell responses. This
is not due to the inability of DCs to process or present antigens,
but just to migrate toward T cells. Because Eps8 is not ex-
pressed in T cells and is not required for the phenotypical and
functional maturation of DCs, in its absence, impairment of
induction of immunity in vivo is owed primarily to the incapacity
of DCs to reach DLNs for T cell activation. Hence, differently from
other actin-binding proteins such as mDia1 and WASP that are
involved in several other properties of DCs (Bouma et al., 2007;
Bouma et al., 2009; Burns et al., 2001; Calle et al., 2004; Mony-
penny et al., 2010; Tanizaki et al., 2010), Eps8 has a unique
activity solely in DC migration. Indirectly, our results indicate
also that DCmigration from the site of inflammation is necessary
for the induction of immunity because DCs that are still capable
of driving T cell responses, but unable to reach the DLN, cannot
initiate immune responses.
Together, these results point to a unique and nonredundant
role of Eps8 in the polarized migration of DCs. Given themunity 35, 388–399, September 23, 2011 ª2011 Elsevier Inc. 397
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DC Migration Requires the Actin Capper Eps8recognized ability of pathogens, primarily viruses, to interfere
with the antigen-processing machinery as well as the migratory
property of DCs (Lambotin et al., 2010; Theodoridis et al.,
2011), it would be interesting to address in future studieswhether
also the actin capping activity of Eps8 could be a target of
immune escape mechanisms.
EXPERIMENTAL PROCEDURES
All animal experiments were conducted in accordance with national guidelines
and were approved by the ethics committee of the AnimalWelfare Office of the
Italian Work Ministry and conformed to the legal mandates and Italian guide-
lines for the care and maintenance of laboratory animals.
In Vivo T Cell Proliferation Assay
Flow cytometry-purified CD4+CD25–CD462L+ naive T cells isolated from
spleen of OT-II TCR Ly5.2+ mice were labeled with 1.25 mMCFSE. CFSE naive
OT-II T cells (2 million) were injected intravenously in C57BL/6 Ly5.1+ recipient
mice. After 24 hr, 3 3 105 OVA-loaded matured Eps8/ or WT BMDCs were
injected in the right or in the left footpad, respectively. After 3 days, popliteal
DLNs were removed and T cells proliferation (CFSE dilution) was assessed
by flow cytometry.
In Vitro Antigen Presentation to T Cell by BMDCs
CD4+CD25–CD462L+ naive T cells isolated from spleen of OT-II TCR Ly5.2+
mice were labeled with 5mM of CFSE and cocultured with Eps8/ or WT
OVA-loaded BMDCs for 3 or 5 days in round- or flat-bottom 96-well plates.
T cells proliferationwasassessedbyCFSEdilutionby flowcytometry. Superna-
tants were collected and cytokine content was analyzed with cytometric bead
array in accordance with the manufacturer’s instructions (BD Biosciences).
Contact Hypersensitivity
Contact hypersensitivity (CHS) was carried as described (Wang et al., 1997a).
In brief, for sensitization, Eps8/ or WT mice were painted (day 0) on shaved
abdominal skin with 100 ml of 3% OXA in 4:1 acetone:olive oil solution. After
5 days, mice were challenged by the application of 10 ml of OXA (1%) on each
side of the right ear, whereas the left ear received the vehicle alone. CHS re-
sponse was determined by measuring the size of the antigen-painted ear com-
pared to that of the vehicle-treated controlateral ear. The results are expressed
as fold of size increase calculated over vehicle-treated controlateral ear. For
histological analysis, mouse ears sections were stained with hematoxylin-eosin.
Trafficking to the DLNs of BMDC Injected into the Footpad
BMDCs from WT or Eps8/ mice treated with 200 ng/ml LPS for 6 hr were
labeled respectively with 5mM eFluor 670 or 5mM CFSE. WT and Eps8/
BMDCs (1.5 3 105) at a 1:1 ratio were suspended in 20mL PBS and injected
subcutaneously into the hind footpads of C57BL/6 mice. After 24 hr, popliteal
DLNswere either digested so that cells suspensions could be obtained for flow
cytometry analysis or frozen in cryomatrix and sectioned in 10 mm slices for
immunofluorescence analysis.
Statistical Analysis
Student’s paired t test was used for determining the statistical significance.
Significance was defined as *p < 0.05; **p < 0.01; and ***p < 0.001. Statistic
calculations were performed with JMP 5.1 software (SAS Cary).
SUPPLEMENTAL INFORMATION
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